Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-035060

Director bought 2,000 shares at an average $2.11 ($4,227)

From the SEC's structured data for this filing

Trades in this filing

Winer Gary M · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-06 Purchase : show line 1 in the form +1,000 $2.13 $2,127 8,500 D
2022-06-07 Purchase : show line 2 in the form +1,000 $2.10 $2,100 9,500 D
Open-market purchases · 2,000 sh · avg $2.11 · $4,227
Loading xslF345X03/doc4.xml…